Paul Beales
We have expertise on artificial cells. vesicle-based drug delivery and LNP formulations , including:
1. Metabolite-triggered drug release systems.
2. Vesicle in hydrogel drug delivery depots that can be sprayed over target tissue during laparoscopic surgery.
3. Hybrid vesicles with tuneable drug release rates.
4. Enhanced LNP formulations for improved storage stability and tissue-specific targeting.
5. Artificial cells for diagnostic sensing with engineered signal transduction mechanisms.
